Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cerebret 212.5mg Injection

Prescription Icon
Prescription Required

Marketer

Scotmed Care Pvt Ltd

Salt Composition

Cerebroprotein Hydrolysate (212.5mg)

Overview Cerebret 212.5mg Injection

NeuroMend 212.5mg Injection, a prescription medication, treats stroke, traumatic brain injury, and Alzheimer's disease. Administered by a healthcare professional, it may be used solely or alongside other therapies, depending on the specific condition. Consistent daily dosing helps maintain therapeutic blood levels. Missed doses should be taken immediately upon recall; complete the prescribed course regardless of symptom improvement. Discontinuation requires physician consultation. Avoid use with epilepsy or severe renal impairment. While generally well-tolerated, potential side effects include injection site discomfort (pain/redness), nausea, headache, and vertigo. Dizziness and somnolence may occur; avoid driving or activities requiring alertness until effects are known.

Primary Ingredients of Cerebret 212.5mg Injection

No information provided. Please provide the text you wish me to rewrite.

Uses of Cerebret 212.5mg Injection

Dementia due to Alzheimer's | Cerebrovascular accident | Traumatic brain injury

Major Benefits of Cerebret 212.5mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Cerebret 212.5mg Injection:

  • Headache
  • Nausea
  • Vertigo
  • Sweating
  • Fever
  • Anxiety
  • Hallucination
  • Confusion
  • Agitation
  • Flu-like symptoms

How to use Cerebret 212.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Cerebret 212.5mg Injection works:

NeuroMend 212.5mg Injection promotes neuronal regeneration within the brain, enhancing nerve cell survival and repair.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Cerebret 212.5mg Injection lacks established safety data. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Cerebret 212.5mg Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Cerebret 212.5mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Cerebret 212.5mg Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if these effects are experienced.

KidneyKidneyUNSAFE

Cerebret 212.5mg Injection is likely unsuitable for individuals with impaired kidney function and should be avoided. Medical advice is recommended.

LiverLiverCONSULT YOUR DOCTOR

Data regarding the administration of Cerebret 212.5mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.

What if you forget to take Cerebret 212.5mg Injection :

Should you forget a Cerebret 212.5mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cerebret 212.5mg Injection

LabelValue
Chemical Type Modified amino acids
Developing Habits No.
Treatment Category Central Nervous System (CNS)

FAQs on Cerebret 212.5mg Injection

Derived from pig brain tissue, cerebroprotein hydrolysate is an extract that supports nerve health and enhances cognitive function by acting on the central nervous system.
Administered by a healthcare professional via injection, the treatment takes approximately 15 minutes. The duration may adjust based on the dose and delivery method.
Administered either intramuscularly or intravenously.
Symptom improvement may be noticeable within two weeks, though this varies depending on individual factors such as your condition, treatment response, and prescribed dosage.
Cerebret 212.5mg Injection should be administered daily for 10 to 20 days, as recommended. Treatment duration may vary depending on individual patient factors, such as age and condition.
While this medication hasn't been shown to worsen kidney disease, it shouldn't be given to patients with severe kidney impairment.
Hospital administration of Cerebret 212.5mg Injection by qualified professionals minimizes overdose risk. However, should an overdose be suspected, the physician will immediately provide emergency care.
Cerebret 212.5mg Injectio...
994
MRP 1,150
13% off